170 related articles for article (PubMed ID: 34253763)
1. Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells.
Dash S; Yoder S; Mesa T; Smith A; Cen L; Eschrich S; Armaiz-Pena GN; Monteiro ANA
Sci Rep; 2021 Jul; 11(1):14334. PubMed ID: 34253763
[TBL] [Abstract][Full Text] [Related]
2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
3. Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine.
Gjyshi A; Dash S; Cen L; Cheng CH; Zhang C; Yoder SJ; Teer JK; Armaiz-Pena GN; Monteiro ANA
Sci Rep; 2018 May; 8(1):8291. PubMed ID: 29844388
[TBL] [Abstract][Full Text] [Related]
4. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
5. YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.
Hua G; Lv X; He C; Remmenga SW; Rodabough KJ; Dong J; Yang L; Lele SM; Yang P; Zhou J; Karst A; Drapkin RI; Davis JS; Wang C
Oncogene; 2016 Apr; 35(17):2247-65. PubMed ID: 26364602
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 expression in fallopian tube epithelium drives cell migration.
Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
[TBL] [Abstract][Full Text] [Related]
7. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R
Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882
[TBL] [Abstract][Full Text] [Related]
9. High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
Kim J; Coffey DM; Creighton CJ; Yu Z; Hawkins SM; Matzuk MM
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3921-6. PubMed ID: 22331912
[TBL] [Abstract][Full Text] [Related]
10. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.
Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A
Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
[TBL] [Abstract][Full Text] [Related]
12. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.
Xian W; Miron A; Roh M; Semmel DR; Yassin Y; Garber J; Oliva E; Goodman A; Mehra K; Berkowitz RS; Crum CP; Quade BJ
J Pathol; 2010 Jan; 220(1):17-23. PubMed ID: 19834951
[TBL] [Abstract][Full Text] [Related]
13. Human fallopian tube epithelium co-culture with murine ovarian follicles reveals crosstalk in the reproductive cycle.
Zhu J; Xu Y; Rashedi AS; Pavone ME; Kim JJ; Woodruff TK; Burdette JE
Mol Hum Reprod; 2016 Nov; 22(11):756-767. PubMed ID: 27542947
[TBL] [Abstract][Full Text] [Related]
14. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
15. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.
Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ
Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer and normal fallopian tube high WFDC2 expression does not correlate with HE4 serum level.
Gąsiorowska E; Walkowiak GP; Warchoł W; Lemańska A; Jankowska A; Nowak-Markwitz E
Ginekol Pol; 2015 May; 86(5):335-9. PubMed ID: 26117969
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.
O'Shannessy DJ; Jackson SM; Twine NC; Hoffman BE; Dezso Z; Agoulnik SI; Somers EB
Int J Mol Sci; 2013 Jul; 14(7):13687-703. PubMed ID: 23880844
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells.
Reavis HD; Gysler SM; McKenney GB; Knarr M; Lusk HJ; Rawat P; Rendulich HS; Mitchell MA; Berger DS; Moon JS; Ryu S; Mainigi M; Iwanicki MP; Hoon DS; Sanchez LM; Drapkin R
JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38271085
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants.
Ronchi S; Facchi S; Di Lauro E; Libera L; Carnevali IW; Zefiro F; Alexandrova E; Rizzo F; Sessa F; Tibiletti MG
Pathol Res Pract; 2024 Mar; 255():155183. PubMed ID: 38364651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
